Suplatast tosilate
-
Suplatast tosilate
structure -
-
CAS No:
94055-76-2
-
Formula:
C16H26NO4S.C7H7O3S
-
Chemical Name:
Suplatast tosilate
-
Synonyms:
Sulfonium,[3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-,4-methylbenzenesulfonate (1:1);Sulfonium,[3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethyl-,salt with 4-methylbenzenesulfonic acid (1:1);Suplatast tosilate;Suplatast tosylate;IPD 1151T;[2-[4-(3-Ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate;(±)-[2-[4-(3-Ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyl]dimethylsulfonium p-toluenesulfonate;160114-29-4;1776086-79-3
- Categories:
-
CAS No:
Description
Suplatast tosilate(IPD 1151T) is a Th2 cytokine inhibitor that attenuates IL-2, IL-5 and IL-13 production and has no effect on IFN-γ production. IC50 value:Target: Th2 cytokine inhibitorSuplatast Tosilate acts as an immunoregulator that suppresses IgE production, eosinophil infiltration and histamine release. Suplatast Tosilate(IPD 1151T) exhibits antiasthmatic, anti-inflammatory and antifibrotic activity in vivo and is orally active.
Characteristics
134
white to off-white
70-73 °C
DMSO: >20mg/mL
Store at RT
LD50 in male, female mice, male, female rats (mg/kg): 81, 96, 96, 93 i.v.; in mice, rats (g/kg): >12.5, >10 orally (Yamashita)
Safety Information
NONH for all modes of transport
3
WR7906000
P201, P202, P281, P308+P313, P405, P501
H361
|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drug Information
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)|Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
(2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)ethyl)dimethylsulfonium p-toluenesulfonate
Suplatast tosilate Use and Manufacturing
Add 5.0 g (15.95 mmol) of intermediate 3 to the reaction flask at 20~30 °C.5.94 g of p-toluenesulfonic acid methyl ester (31.91 mmol), stir to 50-60 ° C, react for 20-24 h, add 10 mL of acetone for 30 minutes, filter, filter cake and add 20 mL of acetone to recrystallize to obtain metformin. 6.8 g, yield 85.0
Suplatast Tosilate is a novel capsular anti-asthmatic agent that suppresses both IgE production, IL-4 and IL-5 synthesis with IC50 above 100 μM.
Computed Properties
Molecular Weight:499.6
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:7
Rotatable Bond Count:10
Exact Mass:499.16984474
Monoisotopic Mass:499.16984474
Topological Polar Surface Area:134
Heavy Atom Count:33
Complexity:500
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Not yet clear
Recommended Suppliers of Suplatast tosilate
-
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates
Learn More Other Chemicals
-
Metaproterenol sulfate
5874-97-5
-
Benproperine phosphate
19428-14-9
-
9-Chloro-2-methyl-5H-pyrazolo[1,5-d][1,4]benzodiazepin-6(7H)-one
84661-23-4
-
Seratrodast Formula
112665-43-7
-
Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1) Formula
151767-02-1
-
Pranlukast Formula
103177-37-3
-
Zileuton Structure
111406-87-2
-
2-[2-(Dimethylamino)ethoxy]ethyl 10H-phenothiazine-10-carboxylate Structure
477-93-0
-
What is 2-Hydroxy-4-methylbenzenesulfonic acid
22356-80-5
-
What is Bitolterol mesylate
30392-41-7